Cytodyn Inc (CYDY)

[Saltz]

It’s called the cost of financing to uplist. They needed more favorable financing than was available to R/S and uplist. NOBODY would have been happy other than the financiers with the terms. While dilution is a necessary component of moving Pro-140 through the approval process management has a responsibility to not get raped in the process. We are in a tight financing position because of the current SP which is a reflection of the string of warrant backed Paulson raises. It’s simple math. The company knows it and anybody with their head in the game knows it. 95% of my position is through Paulson. I get it.